[go: up one dir, main page]

IL145711A0 - Thrombospondin-2 and uses thereof - Google Patents

Thrombospondin-2 and uses thereof

Info

Publication number
IL145711A0
IL145711A0 IL14571100A IL14571100A IL145711A0 IL 145711 A0 IL145711 A0 IL 145711A0 IL 14571100 A IL14571100 A IL 14571100A IL 14571100 A IL14571100 A IL 14571100A IL 145711 A0 IL145711 A0 IL 145711A0
Authority
IL
Israel
Prior art keywords
thrombospondin
Prior art date
Application number
IL14571100A
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of IL145711A0 publication Critical patent/IL145711A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
IL14571100A 1999-03-31 2000-03-24 Thrombospondin-2 and uses thereof IL145711A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12722199P 1999-03-31 1999-03-31
PCT/US2000/007835 WO2000057899A1 (en) 1999-03-31 2000-03-24 Thrombospondin-2 and uses thereof

Publications (1)

Publication Number Publication Date
IL145711A0 true IL145711A0 (en) 2002-07-25

Family

ID=22428951

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14571100A IL145711A0 (en) 1999-03-31 2000-03-24 Thrombospondin-2 and uses thereof

Country Status (7)

Country Link
EP (1) EP1171151A4 (en)
JP (1) JP2002540163A (en)
KR (1) KR20010105403A (en)
AU (1) AU766098B2 (en)
CA (1) CA2368657A1 (en)
IL (1) IL145711A0 (en)
WO (1) WO2000057899A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001279127A1 (en) * 2000-08-01 2002-02-13 University Of Washington Methods and devices to modulate the wound response
TWI233361B (en) 2001-04-13 2005-06-01 Gen Hospital Corp Methods of preventing UVB-induced skin damage
GB0218909D0 (en) * 2002-08-15 2002-09-25 Qinetiq Ltd Histological assessment
US20050220810A1 (en) * 2002-06-25 2005-10-06 Shiseido Company, Ltd. Anti-aging preparation
CN115097133A (en) * 2015-09-09 2022-09-23 私募蛋白质体操作有限公司 Methods for developing personalized drug treatment plans and targeted drug development based on proteomic profiles
KR20230016576A (en) * 2021-07-26 2023-02-02 연세대학교 산학협력단 Novel Antibody for Preventing or Treating Fibrotic Disease

Also Published As

Publication number Publication date
EP1171151A4 (en) 2004-08-04
WO2000057899A1 (en) 2000-10-05
AU3917200A (en) 2000-10-16
JP2002540163A (en) 2002-11-26
AU766098B2 (en) 2003-10-09
KR20010105403A (en) 2001-11-28
CA2368657A1 (en) 2000-10-05
EP1171151A1 (en) 2002-01-16

Similar Documents

Publication Publication Date Title
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
HRP20060251B1 (en) Substituted oxasolidinones and their use
EP1032377A4 (en) Substituted 2-aminoacetamides and the use thereof
GB9812413D0 (en) Compound and its use
DE69927412D1 (en) Phosphitadditive in polyolefinen
AU9667901A (en) Mycoattractants and mycopesticides
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
IL147382A0 (en) Running and testing applications
GB9927332D0 (en) Novel antibody and uses thereof
GB9818914D0 (en) Use
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
GB9806806D0 (en) Peptides and uses thereof
EP1056455A4 (en) Epimorphian compound and its use
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
IL145711A0 (en) Thrombospondin-2 and uses thereof
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
PL341293A1 (en) Beta-lypothropin and application thereof
GB9807503D0 (en) Use
HUP0104954A3 (en) Prv-1 gene and the use thereof
GB9929581D0 (en) Comjpositions and their use